pyrimidine has been researched along with decitabine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Amoreo, CA; Bristow, CA; Buglioni, S; Cardone, L; Carrella, D; Carugo, A; Ciliberto, G; Del Bufalo, D; Di Bernardo, D; Draetta, GF; Fleming, JB; Huang, JK; Iezzi, M; Iuliano, A; Kang, Y; Kim, MP; Lamolinara, A; Manni, I; Melisi, D; Minelli, R; Mottini, C; Robinson, FS; Tomihara, H; Trisciuoglio, D | 1 |
Carraway, H; Durkin, L; Grabowski, D; Gu, X; Hamilton, B; Hasipek, M; Hong, C; Hsi, ED; Jha, BK; Maciejewski, J; Patel, B; Radivoyevitch, T; Sakre, N; Saunthararajah, Y; Schuerger, C; Sobecks, R; Tohme, R; Tomlinson, B; Zidan, AM | 1 |
Fukuda-Kurahashi, Y; Kamachi, K; Kimura, S; Kurahashi, Y; Ureshino, H; Watanabe, T; Yamamoto, Y; Yoshida-Sakai, N | 1 |
3 other study(ies) available for pyrimidine and decitabine
Article | Year |
---|---|
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Decitabine; Drug Repositioning; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction | 2019 |
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Metabolic Networks and Pathways; Mice; Pyrimidines; Uridine Kinase | 2021 |
Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Decitabine; Deoxycytidine Kinase; DNA Methylation; Drug Resistance, Neoplasm; Humans; Leukemia-Lymphoma, Adult T-Cell; Pyridines; Pyrimidines; Uridine Kinase | 2022 |